Aspire Biopharma Holdings, Inc. Common Stock logo

Aspire Biopharma Holdings, Inc. Common Stock

ASBP • NASDAQ

Aspire Biopharma Holdings, Inc. Common Stock is a pharmaceutical preparations company trading on NASDAQ, led by CEO Kraig T. Higginson, with a market cap of $6.3M.

CEOKraig T. Higginson
Market Cap$6.3M
PHARMACEUTICAL PREPARATIONS
Websiteaspirebiolabs.com

Next Earnings

Upcoming earnings announcement for Aspire Biopharma Holdings, Inc. Common Stock

Date
Tuesday, February 24, 2026 (in 2 weeks)
Timing
Before Market Open (3:41 AM New York)
Fiscal Period
Q4 2025

Earnings History

Past 3 earnings reports for Aspire Biopharma Holdings, Inc. Common Stock

DatePeriodEPSEPS SurpriseRevenueRev. SurpriseFiling
Nov 14, 2025Q3 2025
-$0.04
—
$1.9K
—SEC10-Q
Aug 13, 2025Q2 2025
-$0.04
—
-
—SEC10-Q/A
May 14, 2025Q1 2025
-$0.42
—
-
—SEC10-Q
View all filings on SEC EDGAR

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.

Aspire Biopharma Holdings, Inc. Common Stock (ASBP) Q4 2025 Earnings - Capbase